You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ETON Exercise Disclosure
Erdogan-trinkaus Ipek · SEC Form 4 · Filed Nov 12, 2026
Exercise
Calculated transaction value
$54.15K
Erdogan-trinkaus Ipek Chief Commercial Officer
ETON
Eton Pharmaceutcials
ETON
Transaction date
Nov 10, 2026
Public filing date
Nov 12, 2026
Filing lag
Filed 2 days later
ETON daily price context
Close on/before transaction
$67.54
Nov 10, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,500 shares @ $15.47
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001437749-26-036605
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$290.08K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Eton Pharmaceuticals, Inc. ETON Current | Exercise | Nov 10, 2026 | $54.15K |
| Eton Pharmaceuticals, Inc. ETON | Sale | Nov 10, 2026 | $157.2K |
| Eton Pharmaceuticals, Inc. ETON | Sale | Nov 10, 2026 | $78.74K |
| Eton Pharmaceuticals, Inc. ETON | Exercise | Nov 10, 2026 | $0 |